Study Objectives: Although novel hypnotics have recently emerged, there are currently no
data comparing the clinical potency of benzodiazepine receptor agonists (BZRAs) and novel …

Aims To estimate prevalence of last 12‐month nonmedical use (NMU) of benzodiazepines
and Z‐drugs (the nonbenzodiazepine hypnotics zaleplon, zolpidem and zopiclone) in the …

Objective The objective of the study was to characterize the prevalence of polypharmacy
and central nervous system (CNS)-acting medications in patients with epilepsy, and …

Discovery of innovative anxiolytics is severely hampering. Existing anxiolytics are developed
decades ago and are still the therapeutics of choice. Moreover, lack of new drug targets …

The American Academy of Sleep Medicine (AASM) commissioned five Workgroups to
develop quality measures to optimize management and care for patients with common sleep …

Benzodiazepines (BZDs) are among the most widely prescribed drugs in developed
countries, but they have a high potential for tolerance, dependence and misuse. High-dose …

Benzodiazepines continue to be prescribed widely in the management of patients with
insomnia or anxiety disorders, despite the availability and acceptability of alternative …

Anxiety disorders are among the most common psychiatric diagnoses and present in
patients as excessive fear and worry. Many seeking care for symptoms of anxiety disorders …

The use of psychotropic drugs (antipsychotics, benzodiazepines and benzodiazepine-
related drugs, and antidepressants) is common, with a prevalence estimates range of 19 …

Purpose: Investigations suggest non-medical use of prescription drugs (NMUPD) is
associated with heavy drinking and polydrug use among university students. Our aim is to …